- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
10 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals | US$640.89 | 0.2% | 15.3% | US$67.8b | US$677.45 | P/E10.7x | E-4.5% | n/a | ||
| BIOBio-Rad Laboratories | US$782.52 | -1.2% | 51.1% | US$23.5b | US$771.25 | P/E5.8x | E-41.1% | n/a | ||
| STVNStevanato Group | US$26.89 | 2.4% | n/a | US$7.2b | US$27.02 | P/E50x | E3.2% | 0% | ||
| SAGESage Therapeutics | US$45.22 | -0.2% | -24.5% | US$2.7b | US$83.00 | P/E4x | E24.0% | n/a | ||
| ORGOOrganogenesis Holdings | US$15.75 | 2.4% | 309.1% | US$2.1b | US$26.75 | P/E28.9x | E17.9% | n/a | ||
| QUREuniQure | US$36.62 | 3.9% | -5.4% | US$1.7b | US$66.29 | P/E5.6x | E-50.8% | n/a | ||
| ATRSAntares Pharma | US$3.67 | 0% | 32.0% | US$635.7m | US$6.64 | P/E9.7x | E28.4% | n/a | ||
| CPRXCatalyst Pharmaceuticals | US$4.85 | -2.8% | 51.1% | US$520.0m | US$8.30 | P/E6.7x | E8.4% | n/a | ||
| SIGASIGA Technologies | US$6.59 | 0.8% | -8.3% | US$508.3m | n/a | P/E11.3x | E18.0% | n/a | ||
| ELTPElite Pharmaceuticals | US$0.045 | -2.3% | -37.4% | US$47.5m | n/a | P/E7.1x | n/a | n/a |
Page 1 of 1